Impact of 2013 ASCO/CAP guidelines on HER2 determination of invasive breast cancer: A single institution experience using frontline dual-color FISH von Ragazzi, M, Bisagni, A, Gasparini, E, Kuhn, E, Bassano, C, Tamagnini, I, Foroni, M, Bortesi, M, Falco, G, Ferrari, G, Braglia, L, Savoldi, L, Bologna, A, Di Cicilia, R, Bisagni, G, Gardini, G

Volltext

Pathologist’s assistant (PathA) and his/her role in the surgical pathology department: a systematic review and a narrative synthesis von Bortesi, M., Martino, V., Marchetti, M., Cavazza, A., Gardini, G., Zanetti, E., Bassi, M. C., Ghirotto, L., Costantini, M., Piana, Simonetta

Volltext

Hyperthyroidism and pulmonary hypertension von MARVISI, M, BRIANTI, M, MARANI, G, DEL BORELLO, P, BORTESI, M.L, GUARIGLIA, A

Volltext

Effect of oxytocin on nitric oxide activity controlling gonadotropin secretion in humans von Chiodera, P., Volpi, R., Manfredi, G., Bortesi, M. L., Capretti, L., Magotti, M. G., Saccanijotti, G., Coiro, V.

Volltext

Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy von Minari, R., Bordi, P., Del Re, M., Facchinetti, F., Mazzoni, F., Barbieri, F., Camerini, A., Comin, C.E., Gnetti, L., Azzoni, C., Nizzoli, R., Bortesi, B., Rofi, E., Petreni, P., Campanini, N., Rossi, G., Danesi, R., Tiseo, M.

Volltext

Characteristics of Genome Editing Mutations in Cereal Crops von Zhu, Changfu, Bortesi, Luisa, Baysal, Can, Twyman, Richard M., Fischer, Rainer, Capell, Teresa, Schillberg, Stefan, Christou, Paul

Volltext

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer von Viansone, A., Pellegrino, B., Omarini, C., Pistelli, M., Boggiani, D., Sikokis, A., Uliana, V., Zanoni, D., Tommasi, C., Bortesi, B., Bonatti, F., Piacentini, F., Cortesi, L., Camisa, R., Sgargi, P., Michiara, M., Musolino, A.

Volltext

Patterns of CRISPR/Cas9 activity in plants, animals and microbes von Bortesi, Luisa, Zhu, Changfu, Zischewski, Julia, Perez, Lucia, Bassié, Ludovic, Nadi, Riad, Forni, Giobbe, Lade, Sarah Boyd, Soto, Erika, Jin, Xin, Medina, Vicente, Villorbina, Gemma, Muñoz, Pilar, Farré, Gemma, Fischer, Rainer, Twyman, Richard M., Capell, Teresa, Christou, Paul, Schillberg, Stefan

Volltext

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations von Tiseo, M, Gelsomino, F, Boggiani, D, Bortesi, B, Bartolotti, M, Bozzetti, C, Sammarelli, G, Thai, E, Ardizzoni, A

Volltext

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin von Tiseo, M, Bordi, P, Bortesi, B, Boni, L, Boni, C, Baldini, E, Grossi, F, Recchia, F, Zanelli, F, Fontanini, G, Naldi, N, Campanini, N, Azzoni, C, Bordi, C, Ardizzoni, A

Volltext

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents von Casartelli, C., Tommasi, C., Lazzarin, A., Corianò, M., Tornali, C., Serra, O., Campanini, N., Gutiérrez-Enríquez, S., Sikokis, A., Zanoni, D., Minari, R., Bortesi, B., Michiara, M., Boggiani, D., Uliana, V., Llop-Guevara, A., Serra, V., Musolino, A., Pellegrino, B.

Volltext

145P High-risk breast cancer patients with RAD51-low tumors are characterized by good prognosis von Pellegrino, B., Llop-Guevara, A., Campanini, N., Tommasi, C., Javierre, G. Villacampa, Pedretti, F., Bortesi, B., Minari, R., Rapacchi, E., Michiara, M., Boggiani, D., Sikokis, A., Zanoni, D., Silini, E.M., Serra, V., Musolino, A.

Volltext

Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical a... von Pellegrino, B., Cavanna, L., Boggiani, D., Zamagni, C., Frassoldati, A., Schirone, A., Caldara, A., Rocca, A., Gori, S., Piacentini, F., Berardi, R., Brandes, A.A., Foglietta, J., Villa, F., Todeschini, R., Tognetto, M., Naldi, N., Bortesi, B., Montemurro, F., Ardizzoni, A., Boni, L., Musolino, A.

Volltext

Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications von Bogina, G, Zamboni, G, Sapino, A, Bortesi, L, Marconi, M, Lunardi, G, Coati, F, Massocco, A, Molinaro, L, Pegoraro, C, Venturini, M

Volltext

Clinicopathological Characteristics and Molecular Analyses of Multifocal Intraductal Papillary Mucinous Neoplasms of the Pancreas von MATTHAEI, Hanno, NORRIS, Alexis L, CAPELLI, Paola, ZAMBONI, Giuseppe, BORTESI, Laura, FURUKAWA, Toru, EGAWA, Shinichi, ISHIDA, Masaharu, OTTOMO, Shigeru, UNNO, Michiaki, MOTOI, Fuyuhiko, WOLFGANG, Christopher L, TSIATIS, Athanasios C, EDIL, Barish H, CAMERON, John L, ESHLEMAN, James R, SCHULICK, Richard D, MAITRA, Anirban, HRUBAN, Ralph H, OLINO, Kelly, HONG, Seung-Mo, DAL MOLIN, Marco, GOGGINS, Michael G, CANTO, Marcia, HORTON, Karen M, JACKSON, Keith D

Volltext

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy von Negri, F V, Musolino, A, Naldi, N, Bortesi, B, Missale, G, Laccabue, D, Zerbini, A, Camisa, R, Chernyschova, N, Bisagni, G, Loupakis, F, Ruzzo, A, Neri, T M, Ardizzoni, A

Volltext

Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE... von Musolino, A, Cavanna, L, Boggiani, D, Zamagni, C, Frassoldati, A, Caldara, A, Rocca, A, Gori, S, Piacentini, F, Berardi, R, Brandes, AA, Foglietta, J, Villa, F, Pellegrino, B, Todeschini, R, Tognetto, M, Naldi, N, Bortesi, B, Boni, L, Montemurro, F, Ardizzoni, A

Volltext

Recombinant Proteins in Plants: Methods and Protocols von Schillberg, Stefan, Spiegel, Holger

Volltext

Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome von Bogina, G., Munari, E., Marconi, M., Bortesi, L., Turazza, M., Cassandrini, P., Cirillo, M., Duranti, S., Inno, A., Magarotto, R., Nicodemo, M., Picece, V., Lunardi, G., Gori, S.

Volltext

Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice von ZANESI, Nicola, AQEILAN, Rami, MANCINI, Rita, CALIN, George, SCOTT, Charles P, PEKARSKY, Yuri, CROCE, Carlo M, DRUSCO, Alessandra, KAOU, Mohamed, SEVIGNANI, Cinzia, COSTINEAN, Stefan, BORTIASI, Laura, LA ROCCA, Gaspare, KOLDOVSKY, Pavel, VOLINIA, Stefano

Volltext